Zhongping Tan

Title: Zhongping Tan: Innovator in Glycosylated Erythropoietin

Introduction

Zhongping Tan is a notable inventor based in New York, NY, recognized for his contributions to the field of biochemistry, specifically in the development of glycosylated proteins. With a focus on enhancing the functionality of erythropoietin, his work is crucial in advancing therapeutic applications.

Latest Patents

Zhongping Tan holds a patent for "Compositions comprising homogeneously glycosylated erythropoietin." This invention presents isolated homogeneous polyfunctionalized proteins, such as erythropoietin, and isolated glycopeptides. The innovative method described involves preparing polyfunctionalized peptides and proteins through cysteine-free native chemical ligation. This advancement enhances the potential efficacy of treatments by creating proteins with improved structural qualities.

Career Highlights

Zhongping Tan is affiliated with the Sloan Kettering Institute for Cancer Research, where he engages in groundbreaking research that intersects cancer treatment and biochemical innovation. His dedication to improving protein formulations positions him as a leading figure in his field.

Collaborations

Throughout his career, Zhongping Tan has collaborated with prominent colleagues such as Samuel J. Danishefsky and J. David Warren. These partnerships underscore the importance of collaboration in driving scientific discoveries and innovative solutions in biomedicine.

Conclusion

Zhongping Tan's inventive work on glycosylated erythropoietin demonstrates a significant contribution to biochemistry and therapeutic protein development. His patent highlights the ongoing efforts to improve medical treatments through scientific innovation, marking a vital step forward in the quest for effective cancer therapies.